当期报告
莱斯康制药(LXRX)
$莱斯康制药(LXRX)$ 8-K Current report, items 1.01, 5.07, and 9.01 Accession Number: 0001062822-25-000033 Act: 34 Size: 7 MB 网页链接
$莱斯康制药(LXRX)$ 8-K Current report, items 1.01, 5.07, and 9.01 Accession Number: 0001062822-25-000033 Act: 34 Size: 7 MB 网页链接